-
Clinical trials of gene editing therapy have been approved β of thalassemia
Time of Update: 2021-01-22
News () Reporters from the domestic gene editing pioneer EdiGene, Inc. was informed that on January 18, the company announced that China's State Drug Administration Drug Review Center has approved its application for a clinical trial
-
The new coronavirus has many changes, how the gene sequencing follows the rhythm
Time of Update: 2021-01-22
guidelines also state that no matter how many new coronavirus genome sequences are produced, they will have a positive impact on public health only if strategies are developed for the subsequent generation and dissemination of useful and timely results.
-
Chinese scientists have successfully cloned the gene of "ksing" of rice white leaf disease
Time of Update: 2021-01-22
White leaf disease is one of the "three major diseases" in rice production in China, which seriously affects the yield and quality of rice. , before the 1980s, white-leaf disease often led to a 20 to 30 per cent reduction in rice production, up
-
A treatment that reduced bad cholesterol by 61% In animal experiments with gene editing therapy showed lasting results
Time of Update: 2021-01-22
the average blood PCSK9 protein level decreased by 89% over the same six-month period.
-
The first in the country! Boya was approved for clinical treatment of thalassemia in the case of crispr/Cas 9 gene β gene editing therapy
Time of Update: 2021-01-22
ET-01, a generic self-contained CD34 plus hematocyte injection called CRISPR/Cas9 gene modification BCL11A red line enhancer, is an in-development, self-contained, in-body gene-edited cell therapy product for the treatment of transfusion-dependent type β threetic anemia.
-
Chinese experts and scholars have made innovative breakthroughs in gene editing therapy research
Time of Update: 2021-01-22
Hospital, believes that the technology provides a new solution for the cure of viral cornealitis. Hong Jiaxu told reporters in an interview, at present, the treatment of viral corneitis traditional drugs, such as axilove, or corneal
-
BioMarin hemophilia gene therapy Phase III study was successful
Time of Update: 2021-01-22
/> the FDA had previously awarded valoctocogene roxaparvovec breakthrough therapy to identify and treat orphans with severe haemophilia. Valoctocogene roxaparvovec is a genetically modified gene therapy that uses AAV5 virus vectors to deliver
-
The State Drug Administration has approved the listing of high-volume gene sequencers in China
Time of Update: 2021-01-22
in the clinical practice of tumor NGS is mainly used to drive gene sequencing, is an important link in the precise diagnosis and treatment of tumors. The National Drug Administration has approved the NGS-based NextSeq 550Dx gene sequencer developed
-
Domestic first: Boya series because of gene editing therapy products ET-01 was approved into the clinic
Time of Update: 2021-01-22
-dependent thalassemia, NTDT), where people with blood transfusion-dependent anaemia need to rely on blood transfusions for life for life, if no blood transfusion is allowed, and early complications. About EdiGene, Inc. is a clinically advanced
-
The first Phase 3 clinical trial of DMD gene therapy completed the first patient's medication
Time of Update: 2021-01-21
the first Phase 3 clinical trial of gene therapy to treat DMD patients, an important milestone for this patient group, according to a press release.
-
The uerotymut gene expression system
Time of Update: 2021-01-21
The use of expression system to express the purpose gene in mammalian cells is an important means to study gene function and its interaction.
-
Leaf Disk Transformation Using Agrobacterium tumefaciens-Expression of Heterologous Genes in Tobacco
Time of Update: 2021-01-20
The protocol presented here works well in our hands withNicotiana tabacum cultivar “petit havana” mutant SR1 ( 2 ) andAgrobacterium tumefaciens strain LBA4404 ( 3 ) harboring binary vectors conferring kanamycin resistance (100 mg/L).
-
Tools for Expressing Foreign Genes in Plants
Time of Update: 2021-01-19
The spectrum of plant species amenable to transformation is continuously widening.
-
Analysis of Gene Expression in Transgenic Plants
Time of Update: 2021-01-19
Common methods of transcript analysis by Northern and dot-blot hybridizations using nonradioactive probing methods are described.
-
Layout acceleration! A brief analysis of the current situation and trend of gene therapy industry in China
Time of Update: 2021-01-19
of the biopharmaceutical industry. platform for the country's first set of shared laboratories, shared CDMO workshop, shared clinical center as one of the industrial support system. Industrial Park will be completed in 2022 and put into operation in 2023
-
PCR Cloning of Coat Protein Genes
Time of Update: 2021-01-19
The polymerase chain reaction ( PCR ) is used to amplifyDNA between two oligonucleotide primers, of which one is complimentary to a sequence on the (+)-strand and the other to a downstream sequence on the (−)-strand.
-
Engineering High Yields of Secondary Metabolites in Rubia Cell Cultures Through Transformation with Rol Genes
Time of Update: 2021-01-18
cells with therol genes as an example of metabolic engineering of secondary metabolites.
-
Identification of Regulatory Protein Genes Involved in Alkaloid Biosynthesis Using a Transient RNAi System
Time of Update: 2021-01-18
We report here the use of transient RNAi to isolate regulatory factor genes involved in isoquinoline alkaloid biosynthesis inCoptis japonica protoplasts.
-
Stable Transformation of Medicago truncatula cv. Jemalong for Gene Analysis Using Agrobacterium tumefaciens
Time of Update: 2021-01-18
Leaf explants can be used for the transformation of the embryonic stem cells to produce the transgenic somatic embryos for regeneration.
-
Targeted Mutagenesis for Functional Analysis of Gene Duplication in Legumes
Time of Update: 2021-01-18
Here we describe a method for engineering zinc-finger nucleases (ZFNs) for the purpose of creating targeted mutations in the paleopolyploid soybean genome.
